Pertussis Vaccine Market Size, Share, Industry Trends and Forecast to 2030

Pertussis Vaccine Market Size & CAGR in 2021:

The global pertussis vaccine market is expected to reach a market size of USD 1.5 billion in 2021 with a Compound Annual Growth Rate (CAGR) of 4.2% from 2021 to 2026. The increasing focus on vaccination programs and the rising awareness about the importance of immunization are driving the growth of the pertussis vaccine market.

COVID-19 Impact on the Pertussis Vaccine Market:

The COVID-19 pandemic has had a significant impact on the pertussis vaccine market. With the focus on developing vaccines for COVID-19, there has been a shift in resources and attention away from other vaccines, including pertussis vaccines. This has led to disruptions in manufacturing, distribution, and administration of pertussis vaccines in various regions. However, the importance of vaccination in preventing diseases like pertussis has been emphasized during the pandemic, which is expected to drive the demand for pertussis vaccines in the post-COVID era.

Pertussis Vaccine Dynamics:

The pertussis vaccine market is driven by factors such as the increasing prevalence of pertussis infection, government initiatives to promote vaccination, and the growing awareness about the benefits of immunization. Advances in vaccine technology and the development of new formulations with improved efficacy and safety profiles are also contributing to the growth of the pertussis vaccine market. However, challenges such as vaccine hesitancy, supply chain disruptions, and regulatory hurdles may hinder market growth.

Segments and Related Analysis:

The pertussis vaccine market can be segmented based on product type, distribution channel, and region. Product types include whole-cell pertussis vaccines and acellular pertussis vaccines. Distribution channels include hospitals, clinics, and pharmacies. Regionally, the market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. A detailed analysis of each segment provides insights into market trends and opportunities.

Region Analysis:

North America is expected to dominate the pertussis vaccine market due to the high incidence of pertussis cases and strong healthcare infrastructure. Europe and Asia Pacific are also significant markets for pertussis vaccines, driven by government vaccination programs and increasing awareness about disease prevention. Latin America and Middle East & Africa are projected to witness steady growth in the pertussis vaccine market due to improving healthcare systems and rising investments in immunization programs.

Key Market Players and Competitive Landscape:

Key players in the pertussis vaccine market include GlaxoSmithKline, Sanofi Pasteur, Merck & Co., Inc., and Seqirus. These companies are focusing on research and development to introduce new and improved pertussis vaccines. Strategic collaborations, acquisitions, and product launches are common strategies adopted by market players to strengthen their positions in the competitive landscape. A detailed analysis of key market players and their initiatives provides a comprehensive view of the market dynamics.

Recent Happenings in the Pertussis Vaccine Market:

In recent developments, GlaxoSmithKline announced the launch of a new pertussis vaccine with enhanced efficacy. Sanofi Pasteur received approval for a novel pertussis vaccine formulation from regulatory authorities. Merck & Co., Inc. collaborated with research institutions to conduct clinical trials for a next-generation pertussis vaccine. Seqirus expanded its manufacturing capabilities to meet the increasing demand for pertussis vaccines globally. These developments reflect the ongoing efforts of market players to innovate and address the evolving needs of the pertussis vaccine market.